mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.02 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |